Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |